OUTLOOK THERAPEUTICS, INC. Retained Earnings
OUTLOOK THERAPEUTICS, INC. (OTLK) had Retained Earnings of -$653.54 million as of 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-18
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$653.54M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$633.22M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$628.77M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$605.71M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$653.54M 10-Q · filed 2026-08-18 | |
| 2026-03-31 | -$633.22M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | -$628.77M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | -$605.71M 10-Q · filed 2026-08-18 | |
| 2025-06-30 | -$592.42M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$572.26M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | -$525.91M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | -$543.28M 10-K · filed 2025-12-19 | |
| 2024-06-30 | -$548.98M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$593.39M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$479.10M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | -$467.92M 10-K · filed 2024-12-27 | |
| 2023-06-30 | -$454.93M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | -$434.25M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$427.60M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | -$408.94M 10-K · filed 2023-12-22 | |
| 2022-06-30 | -$394.59M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | -$377.05M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | -$357.35M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | -$342.88M 10-K · filed 2022-12-29 | |
| 2021-06-30 | -$329.48M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | -$317.28M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | -$304.18M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | -$289.72M 10-K · filed 2021-12-23 | |
| 2020-06-30 | -$279.80M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | -$276.78M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | -$271.08M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | -$254.48M 10-K · filed 2020-12-23 | |
| 2019-06-30 | -$244.38M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | -$239.94M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | -$229.70M 10-Q · filed 2019-02-14 | |
| 2018-09-30 | -$216.31M 10-K · filed 2019-12-19 | |
| 2018-06-30 | -$204.11M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$195.68M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$188.14M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | -$186.22M 10-K · filed 2018-12-18 | |
| 2017-06-30 | -$179.86M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$174.54M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | -$166.49M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | -$147.37M 10-K · filed 2017-12-29 | -$147.39M 10-K · filed 2016-12-29 |
| 2016-06-30 | -$136.80M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$114.47M 10-Q · filed 2016-06-27 | |
| 2015-09-30 | -$94.06M 10-K · filed 2016-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |